Search

everythinglearnresearchcommunity

for

Search:↓

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

A man thought to have appendicitis actually had a rare pancreas-related condition.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

Improved access to hair removal is crucial for transgender individuals before feminizing surgeries.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Photodynamic therapy shows promise for oral lichen planus but needs more research for consistent results.

Shorter PSADT after prostate surgery is linked to higher risk of death.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Prostaglandin helps regenerate hair follicles after radiation damage.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

PCFCL may have unrecognized subtypes and needs more research.

PPX causes much less hair loss than traditional taxanes.

Doctors should consider comedonic discoid lupus erythematosus to avoid misdiagnosis.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

A patient with a rare form of lupus improved after treatment for skin ulcers and hair loss on the face and scalp.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Anti-phospholipid antibodies in SLE can cause thrombosis and bone necrosis.

Improved collaboration and education between dermatologists and oncologists can enhance care for chemotherapy-related hair loss.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

Early diagnosis and aggressive treatment of lupus nephritis can prevent kidney damage and improve outcomes.